Correlation Engine 2.0
Clear Search sequence regions

  • across (1)
  • antivirals (1)
  • donor (1)
  • donors (6)
  • hepacivirus (1)
  • human (2)
  • liver (1)
  • pilot studies (1)
  • Sizes of these terms reflect their relevance to your search.

    Using organs from donors with treatable infections is a strategy to increase the quality and number of organs for transplantation. For HIV, pilot studies of kidney and liver transplantation from donors with HIV to recipients with HIV demonstrate excellent early outcomes. However, the number of donors and transplants per year remains lower than projected due to several barriers. For HCV, the use of organs from donors with HCV has expanded to recipients without HCV due to safe, effective direct-acting antivirals for HCV, which are well-tolerated in transplant recipients. Studies across organ types demonstrate good outcomes and shorter wait times. Copyright © 2023 Elsevier Inc. All rights reserved.


    Jordan Salas, Kaitlyn Storm, Christine M Durand. Organ Donors with Human Immunodeficiency Virus and Hepatitis C Virus: Expanding the Donor Pool. Infectious disease clinics of North America. 2023 Sep;37(3):641-658

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 37258326

    View Full Text